Genmab Announces U.S. FDA approval of DARZALEX® (daratumumab) in combination with pomalidomide and dexamethasone for relapsed or refractory multiple myeloma

20th June 2017 Uncategorised 0

Genmab

More: Genmab Announces U.S. FDA approval of DARZALEX® (daratumumab) in combination with pomalidomide and dexamethasone for relapsed or refractory multiple myeloma
Source: MDlinx